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2 	  
ABSTRACT 26	  
Background: Although most children with asthma and rhinitis are sensitized to aeroallergens, only 27	  
a minority of sensitized children are symptomatic, implying the underlying operation of efficient 28	  
anti-inflammatory control mechanisms. 29	  
Objective: To identify endogenous control mechanism(s) that attenuate expression of IgE-30	  
associated responsiveness to aeroallergens in sensitized children. 31	  
Methods: In three independent population samples we analysed relationships between 32	  
aeroallergen specific (s)IgE and corresponding sIgG and associated immunophenotypes in atopic 33	  
children and susceptibility to asthma and rhinitis, focussing on responses to house-dust mite 34	  
(HDM) and grass. 35	  
Results: Amongst mite-sensitized children across all populations and at different ages, HDM-36	  
specific IgG:IgE ratios (but not IgG4:IgE) were significantly lower in children with asthma compared 37	  
to those without, and lowest amongst the most severely symptomatic. This finding was mirrored by 38	  
relationships between rhinitis and antibody responses to grass. Depending on age/allergen-39	  
specificity, 20-40% of children with sIgE ≥0.35kU/L were skin test negative, and these also 40	  
expressed the “high sIgG:sIgE” immunophenotype. sIgG1 from these children inhibited allergen-41	  
induced IgE-dependent basophil activation in a dose-dependent fashion. Profiling of aeroallergen-42	  
specific CD4+ Th-memory responses revealed positive associations between sIgG:sIgE ratios and 43	  
IL-10-dependent gene signatures, and significantly higher IL-10/Th2-cytokine(protein) ratios 44	  
amongst non symptomatic children. 45	  
Conclusion: In addition to its role in blocking Th2-effector activation in the late phase allergic 46	  
response, IL-10 is a known IgG1 switch factor. We posit that its production during allergen-induced 47	  
memory responses contributes significantly to attenuation of inflammation via promoting IgG1-48	  
mediated damping of the FcεR1-dependent acute phase reaction. sIgG1:sIgE “balance” may 49	  
represent a readily accessible therapeutic target for asthma/rhinitis control.  50	  
  51	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Key Messages: 61	  
• dissociation between allergic symptomatology and allergen specific (s)IgE status in children is 62	  
associated with high level co-production of sIgG1 viz. high sIgG1:sIgE ratios; 63	  
• an important exemplar is failure to respond to skin prick testing despite ≥0.35kU/L sIgE in 64	  
serum, which is observed in up to 40% of children depending on age/allergen specificity; 65	  
• this atopic immunophenotype manifests in vitro as sIgG1-mediated inhibition of FcεR-66	  
dependent basophil activation, and an accompanying strong IL-10-dependent gene signature 67	  
within corresponding aeroallergen-specific CD4+ Th2-memory responses from the serum 68	  
donors; 69	  
• IL-10 may have the dual function of attenuating activation of late phase-dependent Th2-70	  
effector memory cells, and driving production of sIgG1 which modulates the acute phase 71	  
response 72	  
Capsule Summary: 73	  
In the majority of sensitized children endogenous humoral and cellular regulatory mechanisms 74	  
operative within allergen-specific memory responses act in concert to successfully maintain levels 75	  
of expression of Th2-associated inflammation below clinically relevant thresholds. 76	  
 77	  
 78	  
  79	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INTRODUCTION 80	  
Aeroallergen sensitization is a common feature in childhood asthma1, and IgE-mediated 81	  
inflammation may play a causal role in the disease process2. However, observations that only a 82	  
minority of atopic children have airway symptoms3,4 indicate that pathogenic effects of IgE are 83	  
usually attenuated by as yet poorly defined endogenous control mechanisms. A thorough 84	  
understanding of these mechanisms and how they attenuate the pathologic effects of atopy in 85	  
sensitized but asymptomatic subjects may point towards novel therapeutic targets. 86	  
Current concepts relating to immunoregulation in allergic diseases are derived principally by 87	  
extrapolation from studies of symptomatic atopic patients undergoing courses of high-dose allergen 88	  
immunotherapy, where clinical improvement occurs in the absence of significant reductions in 89	  
specific (s)IgE titres. A variety of evidence is consistent with the hypothesis that these repeated 90	  
high-dose treatments stimulate the generation of specialized cell populations expressing 91	  
“regulatory” phenotypes in particular those producing high levels of IL-105,6 which target the 92	  
subsequent activation of allergen-specific Th-memory cells secreting Th2-effector cytokines 93	  
associated with the late-phase allergic response. These high-dose exposures also selectively boost 94	  
the production of sIgG4 antibodies7, resulting in large increases in sIgG4:sIgE ratios. Similar 95	  
findings have been reported in relation to the remission of occupational allergy in the context of 96	  
very high environmental exposure, which is also associated with high level allergen-specific IL-10 97	  
production8 and high sIgG4:sIgE ratios9  It has been hypothesized that such induced sIgG4 acts to 98	  
attenuate allergy via competing for binding of the allergen responsible for triggering	  IgE-loaded Fcε-99	  
receptors on granulocytes10. 100	  
A crucial question that remains unanswered is the relevance of these mechanisms induced by 101	  
ultra-high exposure to those that control baseline allergic reactivity amongst sensitized subjects at 102	  
the community-wide level, where allergen exposures are within a log-scale lower range, and sIgG4 103	  
is generally only a minor component of allergen-specific IgG responses. The contribution of 104	  
humoral regulatory mechanisms in this context is generally considered minor. However, the 105	  
abundant evidence that “antigen dose selectivity” may be a key determinant of immune-phenotype 106	  
selection during immune induction (an archetypal example being the strikingly different dose-107	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5 	  
response curves for preferential triggering of Th1 versus Th2 immunity11), argues that caution 114	  
should be exercised before extrapolation of findings relating to immunoregulatory mechanisms 115	  
between high and low dose exposure settings. 116	  
In our previous population-based studies, we have demonstrated a strong relationship between 117	  
the risk of asthma and titres of aeroallergen-specific IgE3,12, and obtained evidence that at 118	  
population-wide level cat-specific total IgG (but not corresponding sIgG4) could modify the 119	  
association between cat-specific IgE and asthma13. In the current study, we hypothesized that at 120	  
community level, aeroallergen sensitization may be benign or pathologic, and sought to 121	  
investigate whether the balance between allergen-specific (s)IgE and corresponding sIgG1 may 122	  
be a component of the regulatory process that determines the pathologic potential of IgE-123	  
mediated sensitization. We addressed our hypothesis by bringing together comprehensive data 124	  
on aeroallergen-specific humoral immunity from a series of cohorts. We have focused exclusively 125	  
on atopic children, and included the assessment of sIgG levels to HDM and grass as archetypal 126	  
examples of allergens linked to expression of asthma and rhinitis. In a series of studies, we 127	  
examined the allergen-specific IgG:IgE balance amongst sensitized children in relation to (i) the 128	  
presence, severity and persistence of airway symptoms, (ii) their immediate hypersensitivity skin 129	  
test responses, (iii) the capacity of their sera to arm basophils in vitro for IgE-dependent allergen-130	  
induced degranulation; and (iv) the activation profile of Th2-memory cell populations which 131	  
secrete cytokines that control both aeroallergen-specific antibody production and the late-phase 132	  
allergic response. 133	  
METHODS 134	  
Study design, setting and participants  135	  
We studied three population samples from Perth (Australia) and Manchester (UK): the Western 136	  
Australia Pregnancy Cohort (RAINE)3,13 and the Manchester Asthma and Allergy Study (MAAS)14 137	  
are population-based birth cohorts, and the Childhood Asthma Study (CAS; Perth)15 enrolled 138	  
children at high risk of atopy. We further investigated the observations relating to asthma severity in 139	  
a cross-sectional case-control study of school-age children with or without history of severe asthma 140	  
exacerbation who were equivalently highly HDM-sensitized16. All study populations are described in 141	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6 	  
detail elsewhere3,4,13-16 and studies were approved by research ethics committees. Informed 147	  
consent was obtained from parents. 148	  
Data sources  149	  
Children were followed prospectively, with clinical assessments and blood collection at ages six 150	  
and 14 years (Yr6, Yr14) in RAINE, five and 11 (Yr5, Yr11) in MAAS, and three and five (Yr3, Yr5) 151	  
in CAS. Comparable validated questionnaires were administered to collect information on 152	  
parentally-reported symptoms, and children were skin-prick tested.  153	  
Antibody measurements:  154	  
Antibody assays in the Australian studies were (except where specified) performed in the authors’ 155	  
institution employing reagents supplied gratis by ThermoFisher (Uppsala, Sweden), whereas those 156	  
for the UK studies were performed in the ThermoFisher laboratories  In Australian birth cohorts, we 157	  
measured sIgE against whole HDM and Rye allergen and corresponding sIgG (total and IgG4) 158	  
against major components Der p 1 and Phloem p 1 by ImmunoCAP™ (ThermoFisher, Uppsala, 159	  
Sweden); levels were expressed in µg/L, from which we derived sIgG:sIgE ratios. We used the 160	  
same methodology to measure HDM-specific antibodies in MAAS Yr5. In MAAS Yr11, we 161	  
measured sIgE/sIgG to major allergen components Der p 1 plus Der p 2 and Phl p 1 using 162	  
multiplex Solid-phase Allergen Chip (ImmunoCAP ISAC™, ThermoFisher)17. In a cross-sectional 163	  
study on asthma hospitalizations, we employed dissociation-enhanced immunofluorescence assay 164	  
to measure IgE and IgG1 against the combined major mite components Der p 1 plus Der p 216,18.  165	  
Both the latter assay platforms employ log(s)fold lower allergen coating concentrations than 166	  
ImmunoCAP and accordingly select for higher affinity antibodies.  Such differences militate against 167	  
making direct quantitative comparisons of absolute antibody concentrations across all the cohorts, 168	  
but the key analyses (those relating IgG:IgE ratios to risk for expression of specific clinical 169	  
phenotypes) involve internal comparisons between subgroups within individual cohorts assayed 170	  
with the same methodology.     171	  
Definition of variable 172	  
Current wheeze: Positive response to the question “Has your child had wheezing or whistling in the 173	  
chest in the last 12 months?” 174	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Current asthma: All three of the following: 1) Current wheeze; 2) Current use of asthma 181	  
medication; 3) Physician-diagnosed asthma.  182	  
Asthma severity:  We used asthma severity scale (mild/moderate/severe) developed from the 183	  
Australian asthma management guidelines (www.nationalasthma.org.au).  184	  
Rhinitis: Positive response to “In the past 12 months, has your child had a problem with sneezing, 185	  
or a runny nose, or a blocked nose when he/she did not have a cold or the flu?” 186	  
Sensitization status (skin prick tests-SPT and sIgE): We defined SPT as positive if the wheal 187	  
diameter was ≥3mm, and positive sIgE if the titre was >0·35 kU/L).  SPTs employed whole mite 188	  
extracts (both sites), mixed grass extract (Manchester)  and whole rye grass extract (Perth). 189	  
In vitro cell studies 190	  
To investigate the potential inhibitory effect of sIgG on sIgE-mediated acute inflammatory 191	  
responses, we employed the basophil activation assay19 . Briefly, donor basophils in PBMC were 192	  
acid stripped to remove FcεR1-bound IgE, and passively re-sensitized by incubation for 1hr at 193	  
370C in buffer containing serum that had been pre-assayed to determine levels of Der p 1-sIgG 194	  
and HDM-sIgE. Discrete sets of experiments utilized either a series of individual sera with 195	  
comparable (high level) HDM-sIgE but varying levels of corresponding sIgG, or a series of pooled 196	  
pre-assayed sera premixed to achieve a range of sIgG:sIgE ratios against a background of the 197	  
same concentration of sIgE.  The basophils were activated by addition of Der p 1 to a final 198	  
concentration of 0.1ug/ml and incubated for a further 30 minutes, and the response stopped by 199	  
addition of cold 20mM EDTA. Activation was assessed flow cytometrically via surface expression 200	  
(above low background levels) of CD63 and/or CD203c on basophils20 which were gated as CD3-, 201	  
CD19-, CD14-, HLADR-, CD123hi, FcεR1hi, CD11c-. 202	  
As a follow up to one series of experiments detailed in the text, the sera employed were re-203	  
assayed for Der p 1-specific IgE in order to determine Der p 1-IgG : Der p 1-IgE ratios, and 204	  
relevant basophil activation data were re-expressed in these terms. 205	  
To investigate potential mechanisms which control sIgG:sIgE balance, we performed genome-wide 206	  
expression profiling of HDM-induced CD4+ Th-memory responses in 45  HDM-sensitized RAINE 207	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8 	  
Yr14 subjects selected on the basis of cell availability and moderate-high level sensitization 231	  
(IgE>24ug/L), using established methods. . Cryobanked PBMC from cohort subjects were cultured 232	  
for 24hrs with HDM allergen to activate Th-memory responses, and affinity purified CD4+ T-cells 233	  
were harvested from the cultures for RNA extraction employing DYNAbeads, and subsequent 234	  
expression profiling on Affymetrix microarrays, as detailed previously3,21,22. We examined 235	  
associations between HDM sIgG:sIgE ratios as continuous traits and differentially expressed genes 236	  
activated during the in vitro HDM-specific recall responses. 237	  
Microarray data processing and analyses 238	  
The raw microarray data are available via the Gene Expression Omnibus repository (accession: 239	  
GSE70760; http://www.ncbi.nlm.nih.gov/geo/). Raw microarray data was pre-processed in R 240	  
employing the RMA algorithm and a custom mapping of probe sets to gene23,24 Batch effects were 241	  
identified using principal components analysis and removed using ComBat25. Noisy probe sets 242	  
were filtered out of the analysis employing the pvac algorithm26. Quantitative associations between 243	  
gene expression patterns and log:E ratios were identified employing the Significance Analysis of 244	  
Microarrays (SAM) algorithm27. SAM computes a test statistic derived from the linear regression 245	  
coefficient of each gene on the outcome divided by the sum of the standard error and the square 246	  
root of the residual error. Statistical significance is assessed by repeated permutations of the data.  247	  
Quantitative associations between expression levels of the Th2 module and logGE ratios were 248	  
assessed using Gene Set Analysis22. Upstream Regulator Analysis (URA) was employed to 249	  
identify signalling molecules that have the capacity to drive the observed downstream gene 250	  
expression changes28. URA computes an overlap p-value based on enrichment of known target 251	  
genes of each regulator in the data. An activation Z-score was also calculated to determine if the 252	  
direction of the observed gene expression changes for each regulator is consistent with the 253	  
predictable pattern based on prior studies. 254	  
Statistical analyses 255	  
We assessed differences in antibody titres and ratios thereof by Mann-Whitney U test or Kruskal-256	  
Wallis test, and categorical differences between groups using Chi-squared test (SPSS and 257	  
STATA).  258	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Role of funding sources 270	  
Funding sources had no role in study design, data collection, analysis, interpretation, writing of the 271	  
report, or decision to submit the manuscript.  272	  
 273	  
RESULTS 274	  
 275	  
Table E1 summarizes the characteristics of cohort participants included in the current study. 276	  
Association studies 277	  
Immune response phenotypes underlying symptomatic versus asymptomatic atopy 278	  
We carried out initial analyses among RAINE Yr14 atopic children, and the findings were then 279	  
replicated in other populations and at different ages. Table 1 (top) focuses on asthma and their 280	  
responsiveness to HDM. Amongst the mite-sensitized children in the cohort, HDM sIgE titres 281	  
were significantly higher in those with asthma compared to non-asthmatics, and asthma 282	  
prevalence increased steeply across ascending HDM sIgE quartiles (11%, 16%, 24% and  41% 283	  
respectively, versus 5% in those not sensitized). The higher average sIgE titres in asthmatics 284	  
were mirrored by higher sIgG4 titres, whereas corresponding total sIgG (predominantly IgG1) was 285	  
not increased among asthmatics. A comparable relationship was observed amongst rye grass 286	  
sensitized children between grass sIgE titres and rhinitis prevalence, with corresponding sIgG4 287	  
titres again higher amongst symptomatic children (Table 1 bottom). In both the HDM and grass 288	  
antibody responses, the contribution of sIgG4 to overall sIgG titres was very low (in the order of 289	  
10%; Table 1), and we found no association between sIgG4:sIgE ratios with asthma and rhinitis; 290	  
all subsequent analyses involving IgG were thus focused on total sIgG or the dominant IgG1 291	  
isotype.  292	  
 293	  
Expressing these data as sIgG:sIgE ratios revealed a sharp inverse relationship to clinical 294	  
symptoms, in that amongst mite-sensitized children the HDM sIgG:sIgE ratios were significantly 295	  
lower in RAINE 14Yr children with asthma compared to those without (Table 1 top), and 296	  
corresponding findings relating to grass sIgG:sIgE ratios and rhinitis susceptibility (Table 1 297	  
Pat Holt  4/8/2015 12:53 PM
Deleted: Page Break298	  299	  
Pat Holt  5/8/2015 9:33 AM
Deleted: children in the 300	  
Pat Holt  15/7/2015 1:30 PM
Deleted: /wheeze301	  
Pat Holt  15/7/2015 1:32 PM
Deleted: children 302	  
Pat Holt  15/7/2015 1:32 PM
Deleted: RAINE Yr14: 303	  
Pat Holt  15/7/2015 1:32 PM
Deleted: ,304	  
Pat Holt  4/8/2015 4:07 PM
Deleted: The 305	  
Pat Holt  4/8/2015 4:08 PM
Deleted: HDM-specific306	  
Pat Holt  4/8/2015 4:08 PM
Deleted:  307	  
Pat Holt  4/8/2015 4:09 PM
Deleted: asthma308	  
Pat Holt  4/8/2015 5:32 PM
Deleted: ,309	  
Pat Holt  4/8/2015 4:12 PM
Deleted: -specific310	  
Pat Holt  3/8/2015 1:36 PM
Deleted: strikingly and 311	  
Pat Holt  3/8/2015 1:36 PM
Deleted: /wheeze312	  
Pat Holt  17/7/2015 8:28 AM
Formatted: Font color: Red, Highlight
10 	  
bottom) were comparable. This inverse relationship was replicated across all cohorts and at 313	  
different ages for both wheezing-associated and rhinitis symptoms (Figure 1 and Table E2).  314	  
Asthma severity and persistence 315	  
The analysis amongst HDM-sensitized children with current asthma demonstrated a downward 316	  
trend of sIgG:sIgE ratios with increasing asthma severity against a background of high sIgE which 317	  
was significant in the RAINE cohort but not in MAAS (Table E3).  318	  
In RAINE Yr14, in addition to subjects with current active asthma (physician-diagnosed asthma, 319	  
current asthma medication, current wheeze), we identified a subset of 49 children with well-320	  
controlled asthma (physician-diagnosed asthma, current asthma medication, but no wheeze in the 321	  
previous year). Well-controlled asthmatics in whom symptoms had waned had significantly higher 322	  
sIgG:sIgE ratios, with minimal differences in sIgE (Table E4). There were insufficient numbers 323	  
expressing this phenotype for meaningful analyses in the younger age groups and other cohorts.  324	  
We have previously reported low HDM-sIgG1 in HDM-sensitized children with susceptibility to 325	  
hospitalization for severe asthma exacerbations in a case-control study17 re-analysis of these data 326	  
with addition of further subjects confirmed that low sIgG:sIgE ratio in serum collected at the time of 327	  
exacerbation is a marker of this clinical phenotype (Table E5A). Reduced sIgG:sIgE ratios were 328	  
also observed amongst HDM-sensitized MAAS Yr11 children who had been hospitalised with 329	  
asthma exacerbations (confirmed via transcription of medical records data)29 (Table E5B). 330	  
Mechanistic studies 331	  
Immediate hypersensitivity responses 332	  
(a) sIgG-mediated attenuation of skin prick test reactivity in vivo 333	  
If sIgG attenuated sIgE-mediated responses in the airways, it was likely that SPT responses may 334	  
also be affected. To test this, we examined the relationship between sensitization determined by 335	  
sIgE versus SPT across the cohorts, which revealed a non-random disparity in a major subgroup of 336	  
atopics. For example, 27% of RAINE Yr14 children with HDM-sIgE>0·35kU/L (designated IgE+) and 337	  
44% of those who were IgE+ to grass, were skin test negative to the respective allergens (IgE+/SPT-338	  
). Of note, the frequencies of SPT+ children amongst the IgE- groups were only 3% and 1% for 339	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HDM and grass respectively. A comparable dissociation between sIgE and SPT was observed 372	  
across all ages/cohorts (Figure 2A). Mean sIgE levels in the IgE+/SPT+ children were significantly 373	  
higher than in those who were IgE+/SPT- (Table E6), but multiple IgE+/SPT- children had sIgE titres 374	  
within the 20-30kU/L range. The IgE+/SPT- phenotype was consistently associated with higher 375	  
sIgG:sIgE ratios (Figure 2B; Table E6). Note also the higher prevalence of asthma and rhinitis 376	  
amongst the IgE+/SPT+ relative to IgE+/SPT- children (Figure 2C). 377	  
(b) sIgG-mediated attenuation of sIgE-dependent basophil activation in vitro 378	  
We next used the stripped basophil activation assay to test whether sIgG could attenuate allergen-379	  
triggered basophil activation in vitro. We initially selected a series of individual sera from strongly 380	  
HDM-sensitised RAINE Yr14 participants who were within a narrow band of HDM-specific IgE 381	  
titres, but spanning a broad (~40-fold) range of Der p 1 sIgG titres. Single donor basophils were 382	  
pre-armed with these sera for 1 hour at 370C prior to triggering by addition of Der p 1, and basophil 383	  
activation quantified 30 minute later. A strong trend towards IgG-dose-related inhibition of basophil 384	  
activation is evident in these data (representative experiment in Figure 3A). 385	  
We reasoned also that some of the noise in this plot was likely due to inter-subject variations in 386	  
antibody affinity, allergen component specificity, IgG subclass ratios etc. To reduce this variability, 387	  
we firstly repeated the titration employing pre-assayed serum pools, producing a spectrum of HDM-388	  
specific IgE:IgG ratios against the background of precisely standardized HDM-specific IgE. Der p 1-389	  
triggering of donor basophils pre-armed with these serum pools provided stronger evidence of IgG 390	  
dose-dependent inhibition of basophil activation: the titration in Figure 3B was performed in the 391	  
presence of Der p 1 at 0·1ug/ml, and comparable results were obtained in titrations employing Der 392	  
p 1 at 0·01, 1·0 and 10·0ug/ml (not shown). Secondly, we reassayed all these sera for IgE using a 393	  
modified ImmunoCAP conjugated with Der p 1 as opposed to whole HDM; we recomputed 394	  
sIgG:sIgE ratios as Der p 1-sIgG:sIgE and used these for reanalysis of the basophil activation data 395	  
from Figure 3A/B, with identical conclusions (Figure E1).  396	  
Allergen-specific Th-memory responses and sIgE/sIgG “balance” 397	  
Specific Th-memory cells play a major role in control of antibody production by B-cells, including 398	  
the balance between antibody isotypes. We proceeded to investigate whether the expression of 399	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“high sIgG:sIgE” immunophenotype amongst atopics is reflected by characteristic pattern(s) of 405	  
gene expression in allergen-triggered Th-memory recall responses. Figure 4A is a q-q plot derived 406	  
from the Significance Analysis of Microarrays (SAM) algorithm27, illustrating associations between 407	  
expression levels of individual HDM-induced genes and HDM-specific IgG:IgE ratios in the T-cell 408	  
donors; the differentially expressed genes falling outside the null distribution are negatively 409	  
associated with sIgG:sIgE ratios. The majority of these (listed in Table E7) are key components of 410	  
the atopy-associated Th2 module which we have previously characterized employing network 411	  
analysis of aeroallergen-specific Th-memory responses21,22, and overall expression of this module 412	  
was inversely related to sIgG:sIgE ratios (fdr<0·001, Gene Set Analysis22). The Upstream 413	  
Regulator Analysis28 confirmed that increasing sIgG:sIgE ratios are associated with reduced 414	  
signalling of multiple pathways (particularly those denoting Th2 immunity/T-cell activation), coupled 415	  
with increased IL-10 signalling (Figure 4B;Table E8). Moreover, re-expressing our published HDM-416	  
induced PBMC cytokine response data from the whole population of HDM-sensitized RAINE cohort 417	  
subjects3 and stratification by clinical phenotype demonstrated a reciprocal relationship between IL-418	  
10 and Th2 cytokine production and asthma risk (Figure 4C). Finally, across the same sensitized 419	  
population, Th2 cytokine:IL-10 response ratios also correlated negatively with HDM-sIgG:sIgE 420	  
ratios in serum from respective donors (Spearman’s Correlations, n=527 subjects: IL-5:IL-10, Rho= 421	  
-0.448, p=0.001; IL-13:IL-10, Rho=-0.390,p=0.001; IL-4:IL-10, Rho=-0.203, p=0.01).              422	  
 423	  
DISCUSSION 424	  
 425	  
Our findings indicate that a consistent feature of children who are moderately or highly sensitized, 426	  
but who do not develop asthma and rhinitis, is elevated aeroallergen-specific IgG:IgE antibody ratio 427	  
relative to equivalently sensitized but symptomatic subjects. This association is robust and 428	  
reproducible across different populations and at different ages, it holds for sensitisation-associated 429	  
risk for asthma and rhinitis in relation to sensitization against perennial and seasonal aeroallergens 430	  
(mite and grass respectively), and is demonstrable with different assay platforms. This relationship 431	  
holds for asthma severity and exacerbations, and appears to hold in regard to asthma remission. 432	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We identified a subset of children with positive sIgE, who were skin test negative; these expressed 440	  
the same high sIgG:sIgE immuno-phenotype, and were also differentially resistant to asthma and 441	  
rhinitis, despite high-level sIgE sensitization. Skin test reactivity results from allergen triggering of 442	  
high-affinity IgE receptors on skin mast cells/basophils, and experimental evidence suggests that 443	  
the presence of a sufficiently high sIgG:sIgE ratio during activation may interfere with this process 444	  
via mechanisms which include activation of inhibitory Fc-gamma receptors on mast 445	  
cells/basophils30-34}. Our demonstration of the dose-dependent inhibitory effects of sIgG1 in sera 446	  
from these children in the presence of saturating levels of mite allergen is consistent with such a 447	  
mechanism. However, it is implausible that this alone could account for the overall effects observed 448	  
in our studies in relation to symptoms. The development of persistent/severe aeroallergen-induced 449	  
airway inflammation in sensitized children is considered to derive from a cascade involving 450	  
sequential activation of IgE-dependent acute phase, and Th-memory-cell-dependent late-phase 451	  
reactions(35 and Figure 5). The late-phase reaction is driven by Th2 cytokines including IL-4 and IL-452	  
13, which also control IgE-B-cells maturation36, and repeated cycles of production of these 453	  
cytokines by aeroallergen-triggered Th-memory cells may account for the preferential expansion of 454	  
sIgE relative to sIgG1component of the humoral response in the symptomatic subgroup.  455	  
Our recent studies have established that aeroallergen-specific Th-memory responses in children 456	  
involve activation of complex networks comprising multiple effector and regulatory genes21,22, which 457	  
we hypothesized may include those that can influence the balance between the IgE and IgG1 458	  
antibody isotypes. In this regard, our Th-memory profiling studies in mite-sensitized children 459	  
identified a distinctive pattern of gene expression by aeroallergen-specific CD4+ Th-memory cells 460	  
associated with sIgG:sIgE ratios, which is characteristic of IL-10 exposure of these cells during 461	  
allergen-induced reactivation. The most likely proximal sources of IL-10 in this context are IL-10-462	  
producing “regulatory” cells5,6 which are co-activated to varying degrees in all Th-memory 463	  
responses. The principal immunological function ascribed to IL-10 is control of T-cell-mediated 464	  
inflammation; however, it has also been identified as a significant immunoglobulin switch factor 465	  
driving IgG1 production37. Its release in sufficient amounts during repeated aeroallergen-induced 466	  
Th2-cell activation cycles may thus contribute to slowing the progressive decline in sIgG:sIgE ratios 467	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14 	  
as the sIgE response expands over time in chronically exposed sensitized subjects, by provision of 471	  
an IgG1-trophic signal in parallel with those driving sIgE production. The presence of such sIgG 472	  
above a critical threshold provides a mechanism for attenuation of allergen-triggered FcεR1-473	  
mediated acute-phase inflammation. It is important to note that the mediators released during these 474	  
acute reactions also play a crucial role in recruiting the myeloid and Th2-memory cells responsible 475	  
for the ensuing late-phase response35, and it is plausible that both these components of the allergic 476	  
inflammatory cascade may be subject to co-regulation via complementary IL-10-dependent 477	  
mechanisms (proposed mechanism in Figure 5). 478	  
It is possible that the application of higher resolution technologies that could capture additional 479	  
measures of IgG antibody response maturation such as affinity and major/minor allergen 480	  
component specificity, may further add to its value as a risk assessment tool. The lack of such data 481	  
represents a limitation of our study that should be addressed in follow-up investigations. 482	  
It is of interest to note that children expressing the “asthma susceptible” phenotype also exhibit 483	  
deficient IgG1 antibody production against common respiratory pathogens18,38.  This suggests that 484	  
a generalized deficit in IgG response capacity at mucosal surfaces may be an integral component 485	  
of the high-risk phenotype in relation to inflammatory airway diseases38, further emphasizing the 486	  
need for increased focus on immunological mechanisms beyond IgE in the host response to 487	  
aeroallergens. 488	  
Our findings may be relevant to designing improved desensitization strategies. In particular, our 489	  
observations on direct inhibitory effects of allergen-specific IgG on acute phase-associated basophil 490	  
activation point towards an alternative and testable approach: notably the use of short-course 491	  
allergen-containing vaccines appropriately adjuvantised to selectively promote allergen-specific 492	  
IgG1 synthesis and affinity maturation, conceptually similar to vaccines targeting IgG1-mediated 493	  
protection against microbial pathogens. 494	  
 495	  
  496	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LEGEND FOR TABLE 599	  
 600	  
Table 1: Allergen specific antibody response profiles and respiratory symptoms amongst HDM and 601	  
rye grass sensitized children from the 14yr follow-up of the RAINE community cohort 602	  
Legend:  The study population comprised 521 14yr olds sensitized to HDM (top panel) and 543 603	  
sensitized to grass (bottom panel), as defined by sIgE ≥ 0.35kU/L. Data  shown are group 604	  
mean/standard errors of HDM-specific IgE, IgG (total) and IgG4 levels assayed via ImmunoCAP 605	  
and re-expressed in a common unit (ug/L); IgG:IgE ratios were initially computed for individual 606	  
children, and group mean ratios were then calculated from these. P values derived from Mann 607	  
Whitney U test comparing the two clinical phenotypes. 608	  
 609	  
LEGENDS FOR FIGURES 610	  
 611	  
Figure 1: Relationship between HDM and grass-specific IgG:IgE ratios amongst sensitized children 612	  
and expression of asthma/wheezing or rhinitis  613	  
Children with HDM-specific or grass-specific serum IgE>0·35 kU/L were recruited in the Australian 614	  
RAINE and CAS birth cohorts, and the UK MAAS cohort as specified. 615	  
   *** p<0·001; ** p<0·01; * p<0·05; φ p=0.08 616	  
Figure 2: Dissociation between sensitization status determined by sIgE versus skin prick tests (A) 617	  
and its relationship to sIgG:sIgE ratios (B) and clinical symptoms of asthma and rhinitis (C) in three 618	  
cohorts at different ages. 619	  
Children were selected on the basis of HDM-IgE or grass-IgE titres>0·35 kU/L (“IgE+”) and then 620	  
stratified on the basis of positive or negative responses to relevant allergen into dichotomous IgE+ 621	  
SPT+ and IgE+ SPT- groups. 622	  
Panel A:  The relative frequency of each of the phenotypes within each cohort (analyses in the 5yr 623	  
olds restricted to HDM as the frequency of grass responders was very low). 624	  
Panel B: sIgG:sIgE ratios in each group 625	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Panel C: Relative frequency of subjects expressing symptoms of asthma or rhinitis respectively in 635	  
the HDM and grass-sensitized groups. 636	  
*** p<0·001; ** p<0·01; * p <0·05; φ p=0·078 637	  
 638	  
Figure 3: HDM-induced basophil activation following basophil arming with HDM-IgE-rich sera 639	  
against a background of increasingly high levels of HDM Der p 1-specific IgG. 640	  
Panel A:  Individual sera from 10 Yr14 RAINE participants strongly sensitized to HDM (HDM-IgE 641	  
titres 41-61 ug/L as shown) were used to arm stripped donor basophils prior to activation by 642	  
incubation with HDM-derived Der p 1; resultant basophil activation levels achieved with each serum 643	  
were plotted in rank order as determined by individual specific IgG:IgE ratios. 644	  
Panel B: Preassayed sera from HDM-sensitized Yr14 RAINE participants were used to generate a 645	  
series of pools standardized for HDM-specific IgE level (50ug/L) but with corresponding Der p 1-646	  
specific IgG varying across a logfold range. Data illustrated show levels of basophil activation 647	  
achieved at each specific IgG:IgE ratio. 648	  
 649	  
Figure 4: Variations in HDM-specific Th-memory programming as determinants of specific IgG:IgE 650	  
 ratios and asthma susceptibility amongst RAINE Yr14 participants  651	  
 652	  
Panel A: HDM-IgG:IgE ratios in 45 sensitized RAINE Yr14 participants were tested as a continuous 653	  
trait against corresponding HDM-induced CD4+ T-cell gene expression profiles, employing the SAM 654	  
algorithm.  Data are illustrated as a q-q plot; differentially expressed genes inversely associated 655	  
with the trait (negative scores) are shown in green (see corresponding TableE7). 656	  
Panel B: Candidate upstream regulators driving HDM-induced gene expression patterns 657	  
associated with IgG:IgE ratios were identified utilizing the Ingenuity Pathway URA algorithm, as 658	  
detailed in online methods. Activation Z-scores illustrated for candidate regulators were calculated 659	  
based on the pattern match between observed gene expression patterns and predicted patterns 660	  
based on prior studies. The p-value for IL-10 is based on enrichment of known IL-10 target genes 661	  
identified in the analysis (see corresponding TableE8 for p-values for candidate negative 662	  
regulators). 663	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Panel C: Banked data on HDM-induced cytokine secretion by PBMC from 521 HDM-sensitized 666	  
children (92 asthmatics/429 non asthmatics) was reanalyzed to derive Th2 cytokine:IL-10 ratios in 667	  
the two groups.  668	  
 669	  
Figure 5: Complementary IL-10-dependent pathways for regulation of allergic inflammation 670	  
As detailed in text, IL-10 may play a dual role in attenuation of the allergic inflammatory cascade:  671	  
(i) acting indirectly via promotion of sIgG1 production which modulates the FcεR1-dependent acute 672	  
phase, and (ii) acting directly via modulation of Th2-memory cell activation in the late phase 673	  
response. 674	  
  675	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Table 1 676	  
 677	  
  678	  
RAINE Yr14 
(HDM-sensitized) 
Asthma N Mean ±  S.E P 
HDM-IgE 
No 
Yes 
429 
92 
70·8 ± 79 
187·5 ± 34·4 
<0·001 
 
HDM - IgG 
No 
Yes 
429 
92 
1850·9 ± 81·4 
2126·6 ± 187·4 
0·160 
 
HDM - IgG4 
No 
Yes 
429 
42 
195·3 ±  14·4 
332·8 ± 37·7 
<0·001 
HDM – IgG:IgE ratio 
No 
Yes 
429 
92 
316·4 ± 29·2 
147·1 ± 37·4 
<0·001 
 
HDM - IgG4:IgE ratio 
No 
Yes 
429 
92 
21·0 ± 3·4 
20·0 ± 8·1 
0·90 
RAINE Yr14 
(Grass-sensitized) 
Rhinitis N Mean ±  S.E P 
Grass-IgE 
No 
Yes 
243 
300 
36·7 ± 6·3 
88·2 ± 10·1 
<0.001 
 Grass – IgG 
No 
Yes 
243 
300 
1465·2 ± 103·6 
1518·6 ± 78·8 
0·13 
Grass – IgG4 
No 
Yes 
243 
300 
83·3 ±10·8 
148·0 ± 14·5 
0·001 
Grass - IgG4:IgE ratio 
No 
Yes 
243 
300 
32·0 ± 9·5 
17·5 ± 3·76 
0·11 
Grass - IgG:IgE ratio 
No 
Yes 
243 
300 
422·6 ± 45·7 
204·9 ± 22·4 
<0.001 
23 	  
Figure 1 679	  
 680	  
 681	  
 682	  
 683	  
 684	  685	  
0
200
400
600
800
sI
gG
 : 
sI
gE
 ra
tio
 
Phenotype neg
Phenotype pos
RAINE 6y
(Asthma)
RAINE 6y
(Rhinitis)
MAAS 5y
(Asthma)
  CAS 3y
(Wheeze)
  CAS 5y
(Wheeze)
***
***
**
**
RAINE 14y
(Asthma)
RAINE 14y
(Rhinitis)
***
***
MAAS 11y
(Asthma)
MAAS 11y
(Rhinitis)
*
*φ
Marina Stubbs  6/8/2015 2:42 PM
Deleted: Section Break (Next Page)686	  
Unknown
Formatted: Font:(Default) Arial, 11 pt
Marina Stubbs  6/8/2015 2:42 PM
Formatted: Left
Marina Stubbs  6/8/2015 2:41 PM
Formatted: Centered
Marina Stubbs  6/8/2015 2:41 PM
Deleted: <sp>687	  
24 	  
Figure 2. 688	  
 689	   	  690	  
	  
0
20
40
60
80
100
%
Ig
E+
 S
ub
je
ct
s
IgE+SPT+
IgE+SPT--
RAINE 14y
(HDM)
RAINE 14y
(GRASS)
RAINE 6y
(HDM)
RAINE 6y
(GRASS)
MAAS 5y
(HDM)
CAS 5y
(HDM)
MAAS 11y
(HDM)
MAAS 11y
(GRASS)
0
20
40
60
%
 S
ym
pt
om
at
ic
RAINE 14y
HDM
(Asthma)
RAINE 14y
GRASS
(Rhinitis)
RAINE 6y
HDM
(Asthma)
RAINE 6y
GRASS
(Rhinitis)
MAAS 5y
HDM
(Asthma)
CAS 5y
HDM
(Asthma)
**
**
*
***
φ
MAAS 11y
HDM
(Asthma)
MAAS 11y
GRASS
(Rhinitis)
*
***
A 
B 
C 
0
200
400
600
800
1000
sI
gG
 : 
sI
gE
 ra
tio
 
******
***
**
**
RAINE 14y
(HDM)
RAINE 14y
(GRASS)
RAINE 6y
(HDM)
RAINE 6y
(GRASS)
MAAS 5y
(HDM)
CAS 5y
(HDM)
MAAS 11y
(HDM)
MAAS 11y
(GRASS)
** *
*
Pat Holt  15/7/2015 4:23 PM
Formatted: Numbering: Continuous
25 	  
Figure 3  691	   	  692	   	  693	   	  694	   	  695	   	  696	   	  697	   	  698	   	  699	   	  700	   	  701	   	  702	   	  703	   	  704	   	  705	   	  706	   	  707	   	  708	   	  709	   	  710	   	  711	   	  712	   	  713	   	  714	   	  715	   	  716	   	  717	   	  718	   	  719	   	  720	   	  721	   	  722	   	  723	   	  724	   	  725	   	  726	   	  727	   	   	  728	   	  729	  730	  
0
50
100
150
200
250
0
10
20
30
40
50
Subject Number
   
D
er
p1
 Ig
G
 : 
H
D
M
 Ig
E 
(  
 )
B
asophils %
 activation (   )
1 2 3 4 5 6 7 8 9 10
(51) (61) (60) (46) (55) (48) (43) (41) (43) (44)
(HDM Specific IgE µg/L)

O
6 20 34 47
0
20
40
60
80
Derp1 IgG: HDM IgE ratio
B
as
op
hi
ls
 %
ac
tiv
at
io
n
50 50 50 50IgE µg/L
IgG µg/L 296 977 23691678
6 20 4734Ratio
A 
B 
	  
26 	  
 731	  
 732	  
Marina Stubbs  6/8/2015 3:08 PM
Deleted: 733	  
Marina Stubbs  6/8/2015 3:08 PM
Deleted: Figure 4734	  736	  
Unknown
Formatted: Font:(Default) Arial, 11 pt,
Bold
